Drawing for NICOVAPE

USPTO serial 79327091

NICOVAPE

Reviewed by CopyMark Law Group

Reg. 7002631Status 700Registered
Filing date
Status date
Registration date
Mar 21, 2023
Examiner
NEAL, KELLY L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NICOVAPE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer A. Visintine

Jennifer A. Visintine Thompson Coburn LLPOne US Bank PlazaSt. Louis, MO 63101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Chemical preparations for pharmaceutical purposes, namely for the treatment of smoking and nicotine cessation; chemicals for pharmaceutical use, namely for the treatment of smoking and nicotine cessation; chemical products for pharmaceutical use, namely, chemical preparations for the treatment of smoking and nicotine cessation; chemical products for medical use, namely for the treatment of smoking and nicotine cessation; dietetic preparations adapted for medical use; drugs for medical purposes, namely drugs for the treatment of smoking and nicotine cessation; imitation cigarettes for quitting smoking; medicaments in liquid form for the treatment of smoking and nicotine cessation; medicated preparations for the treatment of smoking and nicotine cessation; medicated preparations for use as anti-smoking devices; pharmaceutical compositions for the treatment of smoking and nicotine cessation; pharmaceutical preparations for the treatment of smoking and nicotine cessation; pharmaceutical preparations for use in discouraging the smoking habit; pharmaceutical products for the treatment of smoking and nicotine cessation; pharmaceutical substances for the treatment of smoking and nicotine cessation; tobacco substitutes for medical purposes, namely for the treatment of smoking and nicotine cessation; tobacco-free cigarettes for medical purposes, namely for the treatment of smoking and nicotine cessationACTIVE—
010Apparatus for administering medicines, namely medical apparatus for the inhalation of pharmaceutical preparations; apparatus for administering pharmaceuticals, namely medical apparatus for the inhalation of pharmaceuticals; apparatus for drug administration, namely medical apparatus for the inhalation of pharmaceutical preparations; medical apparatus for facilitating the inhalation of pharmaceutical preparations; apparatus for medical purposes, namely medical apparatus for facilitating the inhalation of pharmaceutical preparations; medical devices for use in the administration of medicines, namely devices for the inhalation of pharmaceutical preparations; medical devices for use in the administration of pharmaceuticals, namely for the inhalation of pharmaceutical preparations; electronic cigarettes for medical purposes; electronic therapeutic devices, namely electronic cigarettes and vaporizers for medical and therapeutic use; inhalation apparatus for medical use for pharmaceutical preparations; medical apparatus, namely inhalation devices for medical use; pharmaceutical apparatus for the inhalation of pharmaceutical preparations; vaporizers for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 1, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 11, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 11, 2023FIMPFINAL DISPOSITION PROCESSED—
Jun 21, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 21, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 21, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 3, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 3, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 14, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 30, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 29, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 28, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 28, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 17, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 22, 2022RFNTREFUSAL PROCESSED BY IB—
Jun 1, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 1, 2022RFRRREFUSAL PROCESSED BY MPU—
Apr 27, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 26, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 11, 2022DOCKASSIGNED TO EXAMINER—
Dec 17, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 13, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 11, 2021LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 2, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance